Liver-related Deaths in HIV-infected Patients Between 1995 and 2010 in France: the Mortavic 2010 Study in Collaboration with the Agence Nationale De Recherche Sur Le SIDA (ANRS) EN 20 Mortalité 2010 Survey
Overview
Authors
Affiliations
Objectives: The aim of this study was to describe the proportion of liver-related diseases (LRDs) as a cause of death in HIV-infected patients in France and to compare the results with data from our five previous surveys.
Methods: In 2010, 24 clinical wards prospectively recorded all deaths occurring in around 26 000 HIV-infected patients who were regularly followed up. Results were compared with those of previous cross-sectional surveys conducted since 1995 using the same design.
Results: Among 230 reported deaths, 46 (20%) were related to AIDS and 30 (13%) to chronic liver diseases. Eighty per cent of patients who died from LRDs had chronic hepatitis C, 16.7% of them being coinfected with hepatitis B virus (HBV). Among patients who died from an LRD, excessive alcohol consumption was reported in 41%. At death, 80% of patients had undetectable HIV viral load and the median CD4 cell count was 349 cells/μL. The proportion of deaths and the mortality rate attributable to LRDs significantly increased between 1995 and 2005 from 1.5% to 16.7% and from 1.2‰ to 2.0‰, respectively, whereas they tended to decrease in 2010 to 13% and 1.1‰, respectively. Among liver-related causes of death, the proportion represented by hepatocellular carcinoma (HCC) dramatically increased from 5% in 1995 to 40% in 2010 (p = 0.019).
Conclusions: The proportion of LRDs among causes of death in HIV-infected patients seems recently to have reached a plateau after a rapid increase during the decade 1995-2005. LRDs remain a leading cause of death in this population, mainly as a result of hepatitis C virus (HCV) coinfection, HCC representing almost half of liver-related causes of death.
Lembas A, Zaleski A, Mikula T, Kozlowska J, Wiercinska-Drapalo A Viruses. 2025; 17(2).
PMID: 40006998 PMC: 11860511. DOI: 10.3390/v17020243.
Mouinga-Ondeme A, Longo-Pendy N, Moussadji Kinga I, Ngoubangoye B, Moussavou-Boundzanga P, Boundenga L Viruses. 2024; 16(1).
PMID: 38257785 PMC: 10819398. DOI: 10.3390/v16010085.
Lynch E, Russo F Life (Basel). 2023; 13(10).
PMID: 37895356 PMC: 10608432. DOI: 10.3390/life13101975.
Pinato D, Kaneko T, DAlessio A, Forner A, Fessas P, Minguez B JHEP Rep. 2023; 5(7):100741.
PMID: 37274775 PMC: 10238838. DOI: 10.1016/j.jhepr.2023.100741.
Mayaka R, Awuonda M, Ettienne E, Daftary M, Wingate L, Unonu J Inquiry. 2023; 60:469580231171338.
PMID: 37232384 PMC: 10225794. DOI: 10.1177/00469580231171338.